Bristol Myers Squibb Co. BMY
Price
Full chart with drawing tools and indicators
Valuation and ratios (P/E, margins, market value)
Price charts and figures by TradingView, shown in a sealed box: it cannot read this page, but TradingView may count your visit. Prices can be delayed.
Results from SEC filings
| Revenue | $48.2B | -0% | FY ending Dec 31, 2025 |
|---|---|---|---|
| Gross profit | $30.7B | +70% | FY ending Dec 31, 2020 |
| Net income | $7.1B | +179% | FY ending Dec 31, 2025 |
| Earnings per share | $3.46 | +178% | FY ending Dec 31, 2025 |
| Research & development | $10.0B | -11% | FY ending Dec 31, 2025 |
| Cash from operations | $14.2B | -7% | FY ending Dec 31, 2025 |
| Capital spending | $1.3B | +5% | FY ending Dec 31, 2025 |
| Share buybacks | $0 | FY ending Dec 31, 2025 | |
| Dividends paid | $5.0B | +4% | FY ending Dec 31, 2025 |
| Cash | $10.2B | -1% | FY ending Dec 31, 2025 |
| Long-term debt | $42.9B | -10% | FY ending Dec 31, 2025 |
| Shareholders' equity | $18.5B | +13% | FY ending Dec 31, 2025 |
Insider trades
Last 12 months: 0 open-market buys ($0) and 3 sales ($2.3M) by officers, directors and big owners. These are exact: shares times the price each insider reported. Several sales by one person on one day are combined (average price).
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Cristian MassacesiEVP,Chief Med Offr,Head of Dev | Sold | 6,249 | $64.57 | $403K | Sep 9, 2026 |
| Phil M HolzerSVP and Controller | Sold | 500 | $67.50 | $34K | Aug 25, 2026 |
| David V ElkinsEVP, Chief Financial Officer | Soldpre-set plan2 fills | 30,000 | $61.67 avg | $1.9M | Apr 1, 2026 |
Other insider moves (62): pay awards, option exercises, tax withholding, gifts
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Cari GallmanEVP, General Counsel | Tax withholding | 2,332 | $61.15 | $143K | Oct 2, 2026 |
| Cari GallmanEVP, General Counsel | Option exercise | 4,559 | – | – | Oct 2, 2026 |
| Bartie Wendy ShortEVP, Corporate Affairs | Option exercise | 1,236 | $66.92 | $83K | Sep 1, 2026 |
| Bartie Wendy ShortEVP, Corporate Affairs | Tax withholding | 633 | $66.92 | $42K | Sep 1, 2026 |
| Cristian MassacesiEVP,Chief Med Offr,Head of Dev | Tax withholding | 26,175 | $65.31 | $1.7M | Aug 1, 2026 |
| Cari GallmanEVP, General Counsel | Tax withholding | 543 | $65.31 | $35K | Aug 1, 2026 |
| Cristian MassacesiEVP,Chief Med Offr,Head of Dev | Option exercise | 51,172 | – | – | Aug 1, 2026 |
| Cari GallmanEVP, General Counsel | Option exercise | 1,061 | – | – | Aug 1, 2026 |
| Julia A HallerDirector | Option exercise | 20,460 | $53.76 | $1.1M | Jun 15, 2026 |
| Bartie Wendy ShortEVP, Corporate Affairs | Tax withholding | 3,876 | $54.72 | $212K | Jun 3, 2026 |
| Bartie Wendy ShortEVP, Corporate Affairs | Option exercise | 8,040 | – | – | Jun 3, 2026 |
| Adam LenkowskyEVP, Chief Commercial Officer | Tax withholding | 599 | $58.22 | $35K | May 1, 2026 |
| Adam LenkowskyEVP, Chief Commercial Officer | Option exercise | 1,373 | – | – | May 1, 2026 |
| Adam LenkowskyEVP, Chief Commercial Officer | Other | 203 | – | – | May 1, 2026 |
| Karin ShanahanEVP, Chief Supply Chain & Ops | Tax withholding | 1,692 | $61.73 | $104K | Apr 1, 2026 |
| Karin ShanahanEVP, Chief Supply Chain & Ops | Option exercise | 3,307 | – | – | Apr 1, 2026 |
| Christopher S. BoernerChief Executive Officer, Director | Tax withholding4 fills | 21,229 | $60.13 avg | $1.3M | Mar 10, 2026 |
| David V ElkinsEVP, Chief Financial Officer | Tax withholding3 fills | 16,114 | $60.13 avg | $969K | Mar 10, 2026 |
| Karin ShanahanEVP, Chief Supply Chain & Ops | Tax withholding3 fills | 7,760 | $60.13 avg | $467K | Mar 10, 2026 |
| Adam LenkowskyEVP, Chief Commercial Officer | Tax withholding4 fills | 7,015 | $60.13 avg | $422K | Mar 10, 2026 |
| Gregory Scott MeyersEVP, Chief Digital & Tech Off. | Tax withholding3 fills | 6,582 | $60.13 avg | $396K | Mar 10, 2026 |
| Robert M PlengeEVP, Chief Research Officer | Tax withholding3 fills | 4,535 | $60.13 avg | $273K | Mar 10, 2026 |
| Cari GallmanEVP, General Counsel | Tax withholding3 fills | 2,165 | $60.13 avg | $130K | Mar 10, 2026 |
| Ahn Amanda PooleEVP, Chief People Officer | Tax withholding3 fills | 1,992 | $60.13 avg | $120K | Mar 10, 2026 |
| Lynelle HochPresident, Cell Therapy Org. | Tax withholding3 fills | 1,391 | $60.13 avg | $84K | Mar 10, 2026 |
| Phil M HolzerSVP and Controller | Tax withholding3 fills | 1,358 | $60.13 avg | $82K | Mar 10, 2026 |
| Bartie Wendy ShortEVP, Corporate Affairs | Tax withholding3 fills | 1,275 | $60.13 avg | $77K | Mar 10, 2026 |
| Bartie Wendy ShortEVP, Corporate Affairs | Option exercise3 fills | 5,883 | – | – | Mar 10, 2026 |
| Bartie Wendy ShortEVP, Corporate Affairs | Other3 fills | 2,360 | – | – | Mar 10, 2026 |
| Karin ShanahanEVP, Chief Supply Chain & Ops | Option exercise3 fills | 25,501 | – | – | Mar 10, 2026 |
| Karin ShanahanEVP, Chief Supply Chain & Ops | Other3 fills | 10,333 | – | – | Mar 10, 2026 |
| Robert M PlengeEVP, Chief Research Officer | Option exercise3 fills | 17,501 | – | – | Mar 10, 2026 |
| Robert M PlengeEVP, Chief Research Officer | Other3 fills | 7,277 | – | – | Mar 10, 2026 |
| Gregory Scott MeyersEVP, Chief Digital & Tech Off. | Option exercise3 fills | 25,892 | – | – | Mar 10, 2026 |
| Gregory Scott MeyersEVP, Chief Digital & Tech Off. | Other3 fills | 10,377 | – | – | Mar 10, 2026 |
| Adam LenkowskyEVP, Chief Commercial Officer | Option exercise4 fills | 24,071 | – | – | Mar 10, 2026 |
| Adam LenkowskyEVP, Chief Commercial Officer | Other4 fills | 10,360 | – | – | Mar 10, 2026 |
| Phil M HolzerSVP and Controller | Option exercise3 fills | 6,191 | – | – | Mar 10, 2026 |
| Phil M HolzerSVP and Controller | Other3 fills | 2,438 | – | – | Mar 10, 2026 |
| Lynelle HochPresident, Cell Therapy Org. | Option exercise3 fills | 8,192 | – | – | Mar 10, 2026 |
| Lynelle HochPresident, Cell Therapy Org. | Other3 fills | 3,302 | – | – | Mar 10, 2026 |
| Cari GallmanEVP, General Counsel | Option exercise3 fills | 6,980 | – | – | Mar 10, 2026 |
| Cari GallmanEVP, General Counsel | Other3 fills | 2,750 | – | – | Mar 10, 2026 |
| Ahn Amanda PooleEVP, Chief People Officer | Option exercise3 fills | 6,436 | – | – | Mar 10, 2026 |
| Ahn Amanda PooleEVP, Chief People Officer | Other3 fills | 2,546 | – | – | Mar 10, 2026 |
| Christopher S. BoernerChief Executive Officer, Director | Option exercise4 fills | 71,537 | – | – | Mar 10, 2026 |
| Christopher S. BoernerChief Executive Officer, Director | Other4 fills | 30,039 | – | – | Mar 10, 2026 |
| David V ElkinsEVP, Chief Financial Officer | Option exercise3 fills | 62,982 | – | – | Mar 10, 2026 |
| David V ElkinsEVP, Chief Financial Officer | Other3 fills | 24,999 | – | – | Mar 10, 2026 |
| Benjamin HickeyPresident, RayzeBio Org. | Tax withholding | 1,672 | $62.37 | $104K | Feb 27, 2026 |
| Benjamin HickeyPresident, RayzeBio Org. | Option exercise | 3,286 | – | – | Feb 27, 2026 |
| Benjamin HickeyPresident, RayzeBio Org. | Tax withholding | 3,810 | $55.05 | $210K | Feb 1, 2026 |
| Gregory Scott MeyersEVP, Chief Digital & Tech Off. | Tax withholding | 833 | $55.05 | $46K | Feb 1, 2026 |
| Gregory Scott MeyersEVP, Chief Digital & Tech Off. | Option exercise | 2,543 | – | – | Feb 1, 2026 |
| Benjamin HickeyPresident, RayzeBio Org. | Option exercise | 10,079 | – | – | Feb 1, 2026 |
| Karin ShanahanEVP, Chief Supply Chain & Ops | Tax withholding | 3,213 | $46.07 | $148K | Nov 1, 2025 |
| Gregory Scott MeyersEVP, Chief Digital & Tech Off. | Tax withholding | 2,665 | $46.07 | $123K | Nov 1, 2025 |
| Christopher S. BoernerChief Executive Officer, Director | Tax withholding | 1,238 | $46.07 | $57K | Nov 1, 2025 |
| Christopher S. BoernerChief Executive Officer, Director | Option exercise | 2,964 | – | – | Nov 1, 2025 |
| Christopher S. BoernerChief Executive Officer, Director | Other | 544 | – | – | Nov 1, 2025 |
Trades by members of Congress
8 members reported 6 buys and 10 sales since Oct 23, 2024. Amounts are legal ranges, not exact figures.
| Member | Trade | Amount | Traded | Reported | Owner |
|---|---|---|---|---|---|
| Mike Kelly R | Sold | $15K–$50K | May 7, 2026 | Jun 11, 2026 | Spouse |
| Julie Johnson D | Sold | $1,001–$15K | Dec 18, 2025 | Jan 15, 2026 | Joint |
| Julia Letlow R | Sold | $1,001–$15K | Apr 28, 2025 | Jan 13, 2026260 days later | Self |
| Julia Letlow R | Bought | $1,001–$15K | Oct 23, 2024 | Jan 13, 2026447 days later | Self |
| Gilbert Ray Cisneros, Jr. D | Bought | $1,001–$15K | Dec 19, 2025 | Jan 12, 2026 | Self |
| Gilbert Ray Cisneros, Jr. D | Bought | $1,001–$15K | Nov 12, 2025 | Dec 15, 2025 | Self |
| Julie Johnson D | Sold some | $1,001–$15K | Nov 13, 2025 | Dec 11, 2025 | Joint |
| Gilbert Ray Cisneros, Jr. D | Sold some | $1,001–$15K | Oct 9, 2025 | Nov 18, 2025 | Self |
| Val T. Hoyle D | Bought | $1,001–$15K | Oct 29, 2024 | Sep 12, 2025318 days later | Spouse |
| Julie Johnson D | Sold some | $1,001–$15K | Aug 14, 2025 | Sep 11, 2025 | Joint |
| Virginia Foxx R | Sold | $1,001–$15K | Jun 24, 2025 | Jul 3, 2025 | Self |
| Jefferson Shreve R | Sold | $15K–$50K | May 12, 2025 | Jun 22, 2025 | Self |
| Julie Johnson D | Sold | $1,001–$15K | Apr 1, 2025 | May 14, 2025 | Joint |
| Greg Landsman D | Sold | $1,001–$15K | Mar 27, 2025 | Apr 8, 2025 | Joint |
| Julie Johnson D | Bought | $1,001–$15K | Jan 15, 2025 | Feb 12, 2025 | Joint |
| Virginia Foxx R | Bought | $1,001–$15K | Dec 6, 2024 | Jan 6, 2025 | Self |
Latest SEC filings
- Insider plans to sell 144 · Sep 9, 2026
- Insider plans to sell 144 · Aug 25, 2026
- Quarterly report 10-Q · Jul 30, 2026
- News filing: Quarterly results, Public announcement (Reg FD) 8-K · Jul 30, 2026
- News filing: Shareholder vote results 8-K · May 8, 2026
- Quarterly report 10-Q · Apr 30, 2026
- News filing: Quarterly results, Public announcement (Reg FD) 8-K · Apr 30, 2026
- Insider plans to sell 144 · Apr 1, 2026
- Shareholder meeting proxy DEF 14A · Mar 25, 2026
- Annual report 10-K · Feb 11, 2026
- News filing: Quarterly results, Public announcement (Reg FD) 8-K · Feb 5, 2026
- News filing: Public announcement (Reg FD) 8-K · Jan 12, 2026
- News filing: Other news 8-K · Nov 18, 2025
- News filing: Other news 8-K · Nov 10, 2025
- News filing: Other news 8-K · Nov 3, 2025
- Quarterly report 10-Q · Oct 30, 2025
- News filing: Quarterly results, Public announcement (Reg FD) 8-K · Oct 30, 2025
- Insider plans to sell 144 · Sep 2, 2025
- Quarterly report 10-Q · Jul 31, 2025
- News filing: Quarterly results, Public announcement (Reg FD) 8-K · Jul 31, 2025
- News filing: Executive or board change 8-K · Jul 25, 2025
- News filing: Shareholder vote results 8-K · May 7, 2025
- Quarterly report 10-Q · Apr 24, 2025
- News filing: Quarterly results, Public announcement (Reg FD) 8-K · Apr 24, 2025
- Shareholder meeting proxy DEF 14A · Mar 26, 2025
About Bristol Myers Squibb Co.
Business description
- Industry
- Pharmaceutical Preparations
- Sector
- Life Sciences
- Headquarters
- Princeton, NJ
- Incorporated in
- DE
- Fiscal year ends
- December 31
- Exchange
- NYSE
- Also trades as
- CELG-RI
- Filer size
- Large accelerated filer
- SEC company number (CIK)
- 14272
Company figures and insider trades: U.S. Securities and Exchange Commission (EDGAR). Congress trades: Clerk of the U.S. House of Representatives. Nebula is not affiliated with either and this page is not investment advice.